Retractable Technologies (NYSE:RVP) Trading Down 1.5% – Here’s What Happened

Retractable Technologies, Inc. (NYSE:RVP)’s stock price dropped 1.5% during trading on Thursday . The stock traded as low as $0.77 and last traded at $0.81. Approximately 70,675 shares were traded during trading, a decline of 10% from the average daily volume of 78,525 shares. The stock had previously closed at $0.8222.

Retractable Technologies Price Performance

The firm has a market cap of $23.86 million, a PE ratio of -1.48 and a beta of 1.52. The company has a current ratio of 8.57, a quick ratio of 5.92 and a debt-to-equity ratio of 0.01. The company has a 50 day moving average price of $0.88 and a 200 day moving average price of $0.77.

Insider Buying and Selling

In other news, CEO Thomas J. Shaw bought 35,000 shares of the stock in a transaction on Tuesday, October 28th. The shares were bought at an average price of $0.92 per share, with a total value of $32,200.00. Following the completion of the acquisition, the chief executive officer owned 15,802,891 shares of the company’s stock, valued at approximately $14,538,659.72. This trade represents a 0.22% increase in their ownership of the stock. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Insiders acquired 185,897 shares of company stock worth $165,867 in the last quarter. 57.10% of the stock is currently owned by insiders.

Institutional Investors Weigh In On Retractable Technologies

An institutional investor recently raised its position in Retractable Technologies stock. Susquehanna International Group LLP raised its holdings in shares of Retractable Technologies, Inc. (NYSE:RVP) by 135.3% in the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 54,546 shares of the company’s stock after acquiring an additional 31,362 shares during the quarter. Susquehanna International Group LLP owned approximately 0.18% of Retractable Technologies worth $46,000 as of its most recent filing with the Securities and Exchange Commission. 7.58% of the stock is owned by institutional investors.

About Retractable Technologies

Retractable Technologies, Inc designs, develops, manufactures, and markets safety syringes and other safety medical products for the healthcare profession in the United States, rest of North and South America, and internationally. The company offers VanishPoint insulin syringes; tuberculin, insulin, and allergy antigen syringes; small diameter tube adapters; blood collection tube holders; allergy trays; IV safety catheters; Patient Safe syringes and Luer Caps; VanishPoint blood collection sets; EasyPoint needles; and VanishPoint autodisable syringes.